Expertise
Lorem ipsum dolor sit amet, consectetur adipiscing elit
New Product Strategy
Strategic Planning for Long-Term Success
Biopharma companies embark on a long journey to turn scientific breakthroughs into potential medical treatments to help patients. The actions during this journey must support the vision to make it a reality. A successful strategic plan allows the organization to achieve its goals (e.g., portfolio alignment, new market entry, acquisitions, and capital investments) while aligning them to stakeholder/shareholder expectations around financials and social responsibility.
Business plans allow organizations to translate broader strategic plans into operational plans. These operational plans articulate annual goals, resource allocation, and performance expectations. We have extensive experience in developing actionable strategic and operational plans for biopharma companies.
An effective biopharma organization must align structure, processes, and governance. The effectiveness often comes down to governance and decision-making around scientific and commercial issues. We take a strategic approach to designing organizational structures and supporting mechanisms to make biopharma companies nimbler.
Optimizing a Complex Portfolio
A portfolio strategy is necessary when dealing with multiple inline/pipeline assets to ensure optimal positioning combined with effective resource allocation to drive results. With tight R&D budgets and high failure rates in product development, an objective process is required to assess, prioritize, and allocate resources across R&D initiatives. We have institutionalized the portfolio optimization process using best practices and successfully implemented it at many top biopharma companies.
Choosing Therapeutic Area / Disease Area Focus
Therapeutic area or disease strategies are essential for biopharma companies for specialization and long-term value creation. These strategies must be developed using a deeper understanding of clinical, regulatory, medical, and reimbursement pathways. Equally important are the strategic commitment and competency development to win in the chosen area. We collaborate with cross-functional teams to develop these therapeutic area/disease strategies and translate them into actionable strategic roadmaps for execution.
Shaping a Product’s Value Profile
One of the most critical aspects of product development is shaping the drug's target value profile (TVP). A successful TVP development requires an understanding of future competitive and market access dynamics. The TVP must guide the clinical strategy and supporting commercial development activities. We helped numerous clients in shaping their small and large molecule clinical programs using TVPs.
Assessing the Product Potential
A solid understanding of a product's potential is critical to make informed investment decisions. We take a comprehensive approach to evaluating each product's clinical, regulatory, tech ops, and commercial attractiveness. We leverage state-of-the-art valuation tools to support new product planning and business development activities.
Undertaking Life Cycle Planning
Product life cycle strategies range from new indications to label enhancements to end of life cycle strategies. The evidence supporting these life cycle programs' is generated via clinical studies and requires regulatory approval before commercializing these opportunities. LCM strategies, if successful, can increase the lifetime value of the product. See how we help biopharma companies with life cycle planning using our proprietary solution ProLOGS (Product Product Lifecycle Optimization and Growth Strategy for Maximizing Asset Value) to identify and develop value-creating life cycle solutions.
Commercialization Strategy & Excellence
Ensuring Commercial Excellence
Once you launch a product, biopharma companies must closely manage performance while objectively evaluating performance issues. We have developed a best-of-breed performance management framework focused on leading and lagging indicators. Biopharma companies could leverage our proprietary "Brand 360 Audit" framework to evaluate key performance drivers and address them timely for course correction.
Developing Commercialization Strategy
A successful commercialization strategy revolves around creating demand for a given product while ensuring that patients who could benefit from the product gain timely access. The commercial model execution requires alignment of medical, marketing, market access, and supply chain activities. We have assisted several biopharma companies with global and regional commercial strategies—many of the products became quite successful.
Product launches are seminal events for any company in our industry, especially given the development and regulatory process's arduous nature. Biopharma companies must carefully position and differentiate the asset while optimizing market access—careful planning and execution during pre-/peri-/post-launch periods are critical to maximizing the drug's lifetime value. See how we are using our proprietary solution ProComS (New Product Commercialization Strategy to Maximize potential) to help biopharma companies undertake successful commercial planning efforts.